Opinion of the High Council for Public Health regarding the mandatory minimum information requirements for advertising the quadrivalent diphtheria-tetanus-polio-pertussis vaccine Boostrixtetra®.
Author(s): Haut Conseil de la Santé Publique
Publishing year: 2011
Pages: 131
Weekly Epidemiological Bulletin, 2011, n° 10-11, p. 131
In relation to
Our latest news
news
SIBCA 2026: The UrBaCS network presents its solutions for cities and...
news
Physical Activity and Combating a Sedentary Lifestyle: How Does Santé...
news
